★ Sign in to follow
ME

Magnus Erreth

Board Director
Autre membre du conseil
SE·Finansinspektionen
EQL Pharma AB
Insider activity · 24 months2 buys0 salesCumulative net flow
Total declarations
2
Company
1
▲ Purchases (2 ops.)
€11k
▼ Sales (0 ops.)
—

Latest filing published 30 Dec 2025 for EQL Pharma AB, €5,335.

Filing timeline

BuySale
Magnus Erreth

Insider track record

Disclosed buys
2
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-12.4%

Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.

Signal history

Magnus Erreth: trading record in brief

Magnus Erreth is a declared insider of EQL Pharma AB (board member), with filings sourced from Finansinspektionen. Between 23 September 2025 and 30 December 2025, the trades on record add up to 2 filings.

Every open-market trade on record is a purchase: 2 purchases worth €11k, and no sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.

The newest entry dates from 30 December 2025: an open-market purchase of €5,335, in EQL Pharma AB. Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.

Companies and markets linked to Magnus Erreth

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations2 total
  • ▲
    Magnus Erreth
    Annan medlem i bolagets administrations-, lednings- eller kontrollorganExecutivesEQL Pharma AB
    €5,33519FI-SE
    1,000 shares@ €5.3350.0078% mcap100.0% of flowAktieISIN SE0005497732FI:A003V099-1
    Canonical exit: 30 Mar 2026 (T+90)
  • ▲
    Magnus Erreth
    Annan medlem i bolagets administrations-, lednings- eller kontrollorganExecutivesEQL Pharma AB
    €6,14519FI-SE
    1,000 shares@ €6.14510.0090% mcap100.0% of flowAktieISIN SE0005497732FI:A003S651-1
    Canonical exit: 22 Dec 2025 (T+90)

2 of 2 declarations

Related entities

No related entities found.